Archive

vol. 23 , issue 1
33 articles
2023
20
Feb
2023
Hepat Mon

Farnesoid X Receptor Activation Decreases Toll-like Receptor 2 Expression by Upregulating HBeAg Production

Yun Zhou * , Yanyan Li, Min Hu, Huimin Xu, Weiguo Li
|
Final Published
| https://doi.org/10.5812/hepatmon-129128
29
Aug
2023
Hepat Mon

Assessment of the Benefit of Surgical Treatment for Patients with Hepatocellular Carcinoma with Extrahepatic Metastases: A Nomogram for a Propensity Score Matching Study

Bo Luo, Haichuan Long, Ke Zhang, Sikai Wu, Weiwei Chen, Ning Fu, et al.
|
Final Published
| https://doi.org/10.5812/hepatmon-136351
30
Apr
2023

Detection of Hepatitis B Virus Genome with Mutations Outside the Major Hydrophilic Region in the Surface Antigen Isolated from Patients with Coexisting HBsAg and Anti-HBs

Zahra Abbasfard ORCID , Leila Kasraian, Ali Farhadi ORCID , Zahra Jowkar, Saeid Amiri Zadeh Fard ORCID , Narges Nejabat, et al.
|
Final Published
| https://doi.org/10.5812/hepatmon-131307
18
Nov
2023
Hepat Mon

Meta-analysis of the Correlation Between Cognitive Function and Imaging Features in Hepatic Encephalopathy

Chao-Hua Lv, Hong-Sheng Wu, Qing-Song Wan, Cheng-Xiang Shen, Bin Zhou, Xu-Dong Yin, et al.
|
Final Published
| https://doi.org/10.5812/hepatmon-137530
25
Feb
2023
Hepat Mon

Oral Zinc Supplementation in Chronically HEV-Infected Patients Not Responding to Ribavirin Monotherapy

Thomas Horvatits * , Patrick Behrendt, Niels Schuebel, Martina Guthoff, Johannes Wiegand, Anna Harth, et al.
|
Final Published
| https://doi.org/10.5812/hepatmon-130865
17
May
2023
Hepat Mon

Identification of Potential miRNA-mRNA Regulatory Axis of Intrahepatic cccDNA in Patients with Chronic Hepatitis B Virus Infection in the Grey Zone

Wen-Ting Zhang, Antonio Gil Gómez, Macarena López Sánchez, Pérez-Del-Pulgar Sofia, Manuel Romero Gómez, Shuai-Shuai Gao *
|
Final Published
| https://doi.org/10.5812/hepatmon-133782
05
Dec
2023
Hepat Mon

Hepatitis A Chronic Immunity in Iran: A Geographic Information System-Based Study

Kamran Bagheri Lankarani ORCID , Behnam Honarvar ORCID , Ali Davoodi ORCID * , Naeimehossadat Asmarian ORCID , Mohammad Reza Serati ORCID , Mohsen Ali Akbarpour, et al.
|
Final Published
| https://doi.org/10.5812/hepatmon-138329
03
Apr
2023
Hepat Mon

Potentiation of Apoptotic Effect of Combination of Etoposide and Quercetin on HepG2 Liver Cancer Cells

Fereshteh Aslani, Reza Afarin ORCID , Nafiseh Dehghani Madiseh, Hasti Beheshti Nasab, Sajad Monjezi, Somayeh Igder, et al.
|
Final Published
| https://doi.org/10.5812/hepatmon-136194
26
Jul
2023
Hepat Mon

Vitamin D Improves the Lipotoxicity of Liver Cells by Adjusting Epigenetic Characteristics of Genes

Suxia Hu * , Abdusemer Reyimu **
|
Final Published
| https://doi.org/10.5812/hepatmon-133758
04
Apr
2023
Hepat Mon

Creating and Testing a Model to Predict Postoperative Discomfort in Patients with Hepatocellular Carcinoma Receiving Transarterial Chemoembolisation

Ping-Wei Song, Jian-Lei Wang, Tao Wang, Hai-Ning Zou, Ye-Hui Liu *
|
Final Published
| https://doi.org/10.5812/hepatmon-133918
25
Oct
2023
Hepat Mon

Efficacy of Plasma Exchange and a Double-Plasma Molecular Absorption System for Treating Immune Checkpoint Inhibitor-Related Hepatitis

Ying Liu, Lihua Zheng, Wenxiong Xu, Qihuan Xu, Xinhua Li, Qu Lin, et al.
|
Final Published
| https://doi.org/10.5812/hepatmon-137153
15
Apr
2023
Hepat Mon

Real-life Data of Glecaprevir/Pibrentasvir in Chronic Hepatitis C Patients: A Single-center Study

Mehmet Çabalak ORCID * , Tayibe Bal ORCID , Sabahattin Ocak ORCID , İsa Ahmet Bal ORCID , Yusuf Onlen ORCID
|
Final Published
| https://doi.org/10.5812/hepatmon-134406
27
Jun
2023
Hepat Mon

Is There any Need for the Early Detection of Non-alcoholic Fatty Liver Disease in Children with Type 1 Diabetes Mellitus?

Soodeh Salehi ORCID , Sanaz Mehrpour, Shahin Koohmanaee ORCID , Shohreh Maleknejad ORCID , Mohammad Ali Esfandiari ORCID , Saman Maroufizadeh ORCID , et al.
|
Final Published
| https://doi.org/10.5812/hepatmon-135941
20
May
2023
Hepat Mon

Development and Validation of a Prognostic Nomogram Based on Fibrosis-4 Index to Predict 3-Month Mortality in Patients with Hepatic Encephalopathy

Yunxuan Guan, Kai Liu, Xiujun Zhang, Caoyan Qi, Xiaolu Chen, Wenhui Zhang, et al.
|
Final Published
| https://doi.org/10.5812/hepatmon-134771
12
Mar
2023
Hepat Mon

Risk Factors of Non-alcoholic Fatty Liver Disease in the Iranian Adult Population: A Systematic Review and Meta-analysis

Ehsan Amini-Salehi ORCID , Soheil Hassanipour, Farahnaz Joukar ORCID , Amir Ali Daryagasht ORCID , Mohammad-Javad Khosousi ORCID , Maryam Sadat Aleali, et al.
|
Final Published
| https://doi.org/10.5812/hepatmon-131523
13
Mar
2023
Hepat Mon

Rapid Decline of Estimated Glomerular Filtration Rate and Its Effect on Mortality Risk of Patients with Hepatocellular Carcinoma

Florica Gadalean ORCID , Florina Parv ORCID * , Ligia Petrica ORCID , Ioan Sporea ORCID , Bogdan Timar ORCID , Cristina Gluhovschi ORCID , et al.
|
Final Published
| https://doi.org/10.5812/hepatmon-133853
11
Apr
2023
Hepat Mon

Dicer Inhibits Hepatocellular Carcinoma by Inhibiting the Interleukin 6 Pathway

Hongfang Ma, Na Xing, Lin Hou, Jianhua Wu, Ziyue Sha, Fujun Wang, et al.
|
Final Published
| https://doi.org/10.5812/hepatmon-134381
20
Feb
2023
Hepat Mon

Effects of Entecavir on Serum Hepatitis B Virus-DNA, Interferon-γ, and Pregenomic RNA in Patients with Chronic Hepatitis B Virus Infection

Xuyang Gong, Zhitao Chen, Xiaoxia Zhang, Yi Zheng, Heng Zhang *
|
Final Published
| https://doi.org/10.5812/hepatmon-132684
12
Feb
2023
Hepat Mon

Oliveria decumbens Extract Exhibits Hepatoprotective Effects Against Bile Duct Ligation-Induced Liver Injury in Rats by Reducing Oxidative Stress

Vahid Salehi, Haniyeh Malekiasl, Mahdokht Azizi, Sadegh Nouripour-Sisakht ORCID , Maral Gharaghani ORCID , Ali Akbar Saberinejad, et al.
|
Final Published
| https://doi.org/10.5812/hepatmon-131160
02
Aug
2023
Hepat Mon

Predictors for Liver Cirrhosis in Patients with Hepatitis C Virus: A Cross-Sectional Study

Abolfazl Namazi, Pouya Ebrahimi, Arash Sarveazad, Mohsen Khaleghian, Mansour Bahardoust * , Marjan Mokhtare, et al.
|
Final Published
| https://doi.org/10.5812/hepatmon-136164
02
Sep
2023

Resveratrol and Saroglitazar: A Promising Combination for Targeting TGF-β/Smad3 Signaling and Attenuating Inflammatory Response in Nonalcoholic Steatohepatitis in Rats

Mojtaba Rashidi, Reza Afarin ORCID , Maryam Kouchak, Benyamin Kabizadeh, Masoumeh Shamsi, Mahdi Hatami *
|
Final Published
| https://doi.org/10.5812/hepatmon-138237
11
Nov
2023
Hepat Mon

Hepatocellular Carcinoma Diagnosis Based on Ultrasound Images Using Feature Selection Techniques and K-nearest Neighbor Classifier

Fatemeh Azimi Nanvaee, Saeed Setayeshi ORCID *
|
Final Published
| https://doi.org/10.5812/hepatmon-136213
25
Aug
2023
Hepat Mon

Analysis of the Effects of the WeChat Health Management Platform on the Self-care Ability and Quality of Life of Patients with Liver Cancer Undergoing Interventional Therapy

Jing Li, Youyuan Yuan, Jiaqi Chen, Xueqi Wang *
|
Final Published
| https://doi.org/10.5812/hepatmon-137227
01
Nov
2023
Hepat Mon

A Survey of HBV Core/Pre-Core Mutations in Iraqi Patients with Chronic Hepatitis

Abdulhussain Kadhim Jwaziri, Maryam Esghaei ORCID , Mohammad Hadi Karbalaie Niya ORCID , Hadi Sayah, Mohammad Hossein Razizadeh, Ali Gholami, et al.
|
Final Published
| https://doi.org/10.5812/hepatmon-137139
10
Oct
2023
Hepat Mon

Optimization and Application of Quantitative In-house ELISA for Diagnosis of HBsAg and its Correlation with Commercial ELISA and Molecular Kits

Mohammad Ghorbani, Zahra Daryabour, Rahman Shokri, Vahid Kia ORCID , Zohreh Sharifi ORCID , Mahdi Paryan *
|
Final Published
| https://doi.org/10.5812/hepatmon-133150
22
Nov
2023
Hepat Mon

Non-Alcoholic Steatohepatitis and Autoimmune Hepatitis Cirrhosis May Have a Higher Risk of Progression to Hepatocellular Carcinoma

Zohreh Khajehahmadi, Heidar Tavilani, Jamshid Karimi, Mohammad Rafiee, Zahra Arab-Sadeghabadi, Roohollah Mohseni, et al.
|
Final Published
| https://doi.org/10.5812/hepatmon-138449
02
Dec
2023
Hepat Mon

Pretreatment of Exosomes Derived from hUCMSCs with LPS Ameliorates Liver Fibrosis by Inhibiting the Smad3C Through Upregulating MiR-126 in the HSC-T6 Cell Line

Maryam Cheraghzadeh, Emad Matour, Benyamin Kabizadeh, Elham Shakerian, Mojtaba Rashidi *
|
Final Published
| https://doi.org/10.5812/hepatmon-137083
03
Dec
2023
Hepat Mon

Salvage Treatment of Nivolumab and Lenvatinib in Patients with Recurrent Hepatocellular Carcinoma

Lijun Zhou, Wei Peng, Huaxin Duan, Tan Deng *
|
Final Published
| https://doi.org/10.5812/hepatmon-137824
02
Dec
2023
Hepat Mon

Aspartate Aminotransferase to Platelet Ratio Index Before and After the Treatment of Chronic Hepatitis C Patients with Sofosbuvir/Daclatasvir

Mohammad Javad Pourgholamali, Parvin Khalili, Vahid Mirzaei, Zahra Jamali ORCID , Zohreh Rajabi, Afshin Tahmasbi *
|
Final Published
| https://doi.org/10.5812/hepatmon-138049
14
Sep
2023
Hepat Mon

Association Between Proton Pump Inhibitor Use and Spontaneous Bacterial Peritonitis or Hepatic Encephalopathy in Cirrhotic Patients: A Systematic Review and Meta-analysis

Moloud Balafar ORCID , Morteza Ghojazadeh ORCID , Kavous Shahsavarinia ORCID , Zahra Parsian ORCID , Saba Hamedani, Hassan Soleimanpour ORCID *
|
Final Published
| https://doi.org/10.5812/hepatmon-132642
17
Oct
2023
Hepat Mon

Effectiveness and Safety of Tenofovir Alafenamide in Treatment-Naïve and Treatment-Experienced Patients with Chronic Hepatitis B: Results of a Real-World Study from China

Lan-Qing Li, Fa-Da Wang, Jing Zhou, Meng-Lan Wang, Yachao Tao, En-Qiang Chen *
|
Final Published
| https://doi.org/10.5812/hepatmon-135323
29
Nov
2023
Hepat Mon

Effect of Complementary Therapy with Hydro-Ethanolic Extract of Aerial Parts of Portulaca oleracea on Clinical and Paraclinical Findings in Patients with Non-alcoholic Fatty Liver Disease: A Randomized Clinical Trial Protocol

Narges Milkarizi, Hanieh Barghchi, Saba Belyani, Farnood Rajabzadeh, Andisheh Norouzian Ostad, Seyede Yegane Ghelichi Kheyrabadi, et al.
|
Final Published
| https://doi.org/10.5812/hepatmon-138692
11
Nov
2023
Hepat Mon

Determination of Influencers' Characteristics in the Health Sector

Mohammadreza Pourkarim ORCID , Shahnaz Nayebzadeh ORCID * , Seyed Moayed Alavian ORCID , Seyyed Hassan Hataminasab ORCID
|
Final Published
| https://doi.org/10.5812/hepatmon-140317
Social

Special Issue

SCImago Journal & Country Rank

Official COPE member

Author Services

If you have any questions contact us